Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Session 5 - Non Metastatic and Metastatic Castration-Resistant Disease

Metastatic CRPC: Current Treatment

Date

15 Dec 2023

Session

Session 5 - Non Metastatic and Metastatic Castration-Resistant Disease

Topics

Endocrine Therapy

Tumour Site

Prostate Cancer

Presenters

S. Gillessen, CH

Resources

This content is available to ESMO members and event participants.

Login

Resources from the same session

15 Dec 2023

Non Metastatic CRPC: Current Treatment

Presenter: K. Fizazi, FR

Session: Session 5 - Non Metastatic and Metastatic Castration-Resistant Disease

Resources:

Slides

Webcast

15 Dec 2023

PSMA-Based Therapies

Presenter: K. Herrmann, DE

Session: Session 5 - Non Metastatic and Metastatic Castration-Resistant Disease

Resources:

Slides

Webcast

15 Dec 2023

Participant's Clinical Case Discussion: Exceptional and Durable Response to Radium-223 and Suspension of Androgen Deprivation Therapy in a Metastatic Castration-Resistant Prostate Cancer Patient

Presenter: F. Zacchi, IT

Session: Session 5 - Non Metastatic and Metastatic Castration-Resistant Disease

Resources:

Slides

Webcast

15 Dec 2023

Participant's Clinical Case Discussion: Abiraterone Withdrawal Syndrome – A Lasting Response

Presenter: C. Baptista, PT

Session: Session 5 - Non Metastatic and Metastatic Castration-Resistant Disease

Resources:

Slides

Webcast